- Home
- ARQT vs IHS Comparison
ARQT vs IHS Comparison
Compare ARQT & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | IHS |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARQT | IHS |
|---|---|---|
| Price | $20.69 | $8.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $34.00 | $8.29 |
| AVG Volume (30 Days) | ★ 1.9M | 1.0M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | $17.26 |
| Revenue Next Year | $29.39 | $7.87 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $5.10 |
| 52 Week High | $31.77 | $8.95 |
Technical Indicators
Market Signals| Indicator | ARQT | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 65.81 |
| Support Level | $19.60 | $8.14 |
| Resistance Level | $24.56 | $8.74 |
| Average True Range (ATR) | 1.26 | 0.05 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 28.34 | 100.00 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria and Sub-Saharan Africa. The majority of its revenue is derived from Nigeria.